Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,680,337 papers from all fields of science
Search
Sign In
Create Free Account
ERBB3 wt Allele
Known as:
EGF Receptor 3 Gene
, HER3
, V-ERB-B2 Erythroblastic Leukemia Viral Oncogene Homolog 3 (Avian) wt Allele
Human ERBB3 wild-type allele is located within 12q13 and is approximately 23 kb in length. This allele, which encodes receptor tyrosine-protein…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
13 relations
12q13
Cell Proliferation
ERBB2 Signaling Pathway
ERBB3 Receptor Protein-Tyrosine Kinase
Expand
Broader (1)
ERBB3 gene
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Combination of her3 / egfr inhibitor compound Mek inhibitor compounds and methods of use
マーク エックス. スリウコフスキー,
,
ウルフギャング マイケル コーン
2014
Corpus ID: 103699219
The present invention provides a combination comprising MEK inhibitors (such as GDC-0973 or GDC-0623) or a pharmaceutically…
Expand
2014
2014
Investigating a role of HER3 in anti-HER2 target therapy in breast cancer
M. Valentine
2014
Corpus ID: 56693416
2014
2014
Investigating a role of HER3 in anti-HER2 target therapy in breast cancer
K. Hashimoto
2014
Corpus ID: 68446112
Background HER2-positive breast cancer is a poor prognostic subgroup, even if treated with anti-HER2 directed therapy…
Expand
2014
2014
Combination mEq inhibitor compound with a compound inhibitor her3 / egfr and methods of use
Марк Кс. Сливковски
,
Вольфганг Майкл Корн
2014
Corpus ID: 90563161
2013
2013
Abstract P4-16-09: Phase 1b/2 trial of the HER3 inhibitor patritumab (U3-1287) in combination with trastuzumab plus paclitaxel in newly-diagnosed patients with HER2+ metastatic breast cancer (MBC)
S. Carraro
,
D. Campos
,
+6 authors
E. Cazap
2013
Corpus ID: 71481668
Background: Patritumab is a fully human anti-HER3 monoclonal antibody that has shown potent antitumor activity in vivo . HER3 is…
Expand
2013
2013
Diagnosis and treatments associated with her3 inhibitors
Лукас К. Амлер
,
Дэвид Шеймс
2013
Corpus ID: 80152874
1. A method for treating type of cancer in a patient comprising administering a therapeutically effective amount of an inhibitor…
Expand
2012
2012
Abstract P5-19-01: Targeting the HER3-phosphatidyl inositol-3 kinase pathway in breast cancers
R. Cook
,
M. Morrison
,
C. Arteaga
,
C. Perou
2012
Corpus ID: 71310365
Background: Using a mouse model of HER3 ablation in the mammary epithelium, we previously showed that HER3 is required for the…
Expand
2012
2012
Antibody 3 (her3) epidermal growth factor receptor
W·埃利斯
,
S·埃滕伯格
,
A·P·加纳
,
N·豪布斯特
,
C·C·S·昆茨
,
斯普拉格 E·A·赖辛格
2012
Corpus ID: 92493466
The present invention is directed to the HER family receptors, HER3 receptor interactions e.g. antibody or fragment thereof. In…
Expand
2010
2010
Cell line and drug-dependent effect of ERBB3 on cancer cell proliferation, chemosensitivity, and multidrug actions
Bo Chen
,
Rui Mao
,
Hongjie Wang
,
J. She
2010
Corpus ID: 59029231
Correspondence: Jin-Xiong She Center for Biotechnology and Genomic Medicine, Medical College of Georgia, 1120 15th Street…
Expand
2010
2010
Genetics: HER3 overexpression in breast cancer conveys a poor prognosis
L. Richards
Nature Reviews Clinical Oncology
2010
Corpus ID: 45446042
a highly promising and clinically applicable candidate.” tumor samples from 4,046 patients with invasive breast carcinoma were…
Expand